Department of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University, No.95, Yongan Road, Xicheng District, Beijing, 100050, People's Republic of China.
Department of Internal Medical, Medical Health Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, People's Republic of China.
BMC Cardiovasc Disord. 2021 Mar 4;21(1):122. doi: 10.1186/s12872-021-01933-7.
Whether very elderly women with acute coronary syndromes (ACS) should receive aggressive percutaneous coronary intervention (PCI) is still controversial. We assessed the effectiveness and long-term clinical outcomes of successful PCI in this population and identified prognostic factors which might contribute to the incidence of major adverse cardiovascular and cerebrovascular events (MACCE) in the very elderly female PCI cohort.
Female ACS patients aged ≥ 80 years were consecutively enrolled (n = 729) into the study. All the patients were divided into female PCI group (n = 232) and medical group (n = 497). MACCE was followed up, including non-fatal myocardial infarction (MI), stroke, heart failure requiring hospitalization (HFRH), cardiovascular (CV) death, and the composite of them. After propensity score matching (1:1), the incidences of MACCE were compared between the two groups. Clinical and coronary artery lesion characteristics were compared between the female PCI patients with (n = 56) and without MACCE (n = 176). Multivariate Cox regression analysis was performed to identify risk factors which independently associated with MACCE in the female PCI patients. MACCE of male PCI patients, who aged ≥ 80 years and hospitalized in the same period (n = 264), was also compared with that of the female PCI patients.
A total of 32% very elderly female ACS patients received PCI in the present study. (1) Compared to female medical group, PCI procedure significantly alleviated the risks of MACCE: non-fatal MI (6.2% vs. 20.2%, P < 0.001), HFRH (10.9% vs. 22.5%, P = 0.012), CV death (12.4% vs. 28.7%, P < 0.001) and the composite MACCE (24.0% vs. 44.2%, P < 0.001) during the median follow-up period of 36 months. (2) Between very elderly female and male PCI patients, there were no significant differences in occurrence of MACCE (P = 0.232) and CV death (P = 0.951). (3) Multivariate Cox analysis revealed that ST-segment elevation myocardial infarction (STEMI) (HR 1.944, 95% CI 1.11-3.403, P = 0.02) and elevated log- N-Terminal pro-brain natriuretic peptide (NT-proBNP) (HR 1.689, 95% CI 1.029-2.773, P = 0.038) were independently associated with the incidence of MACCE in the female PCI patients.
PCI procedure significantly attenuated the risk of MACCE and improved the long-term clinical outcomes in very elderly female ACS patients. Aggressive PCI strategy may be reasonable in this population.
对于急性冠状动脉综合征(ACS)的非常高龄女性患者,是否应接受积极的经皮冠状动脉介入治疗(PCI)仍存在争议。我们评估了该人群中成功 PCI 的有效性和长期临床结局,并确定了可能导致非常高龄女性 PCI 队列中主要不良心血管和脑血管事件(MACCE)发生的预后因素。
连续纳入年龄≥80 岁的女性 ACS 患者(n=729)入组研究。所有患者均分为女性 PCI 组(n=232)和药物治疗组(n=497)。随访 MACCE,包括非致死性心肌梗死(MI)、卒中和需要住院的心衰(HFRH)、心血管(CV)死亡以及这些事件的复合事件。经倾向评分匹配(1:1)后,比较两组 MACCE 的发生率。比较女性 PCI 患者中发生 MACCE(n=56)和未发生 MACCE(n=176)患者的临床和冠状动脉病变特征。多变量 Cox 回归分析确定与女性 PCI 患者 MACCE 独立相关的风险因素。还比较了同期年龄≥80 岁并住院的男性 PCI 患者(n=264)的 MACCE 与女性 PCI 患者的 MACCE。
本研究中,共有 32%的非常高龄女性 ACS 患者接受了 PCI。(1)与女性药物治疗组相比,PCI 术显著降低了 MACCE 的风险:非致死性 MI(6.2% vs. 20.2%,P<0.001)、HFRH(10.9% vs. 22.5%,P=0.012)、CV 死亡(12.4% vs. 28.7%,P<0.001)和复合 MACCE(24.0% vs. 44.2%,P<0.001)。中位随访 36 个月期间。(2)在非常高龄女性和男性 PCI 患者中,MACCE(P=0.232)和 CV 死亡(P=0.951)的发生率无显著差异。(3)多变量 Cox 分析显示 ST 段抬高型心肌梗死(STEMI)(HR 1.944,95%CI 1.11-3.403,P=0.02)和升高的 N 末端脑利钠肽前体(NT-proBNP)(HR 1.689,95%CI 1.029-2.773,P=0.038)与女性 PCI 患者 MACCE 的发生率独立相关。
PCI 术可显著降低非常高龄女性 ACS 患者 MACCE 的风险,并改善其长期临床结局。在该人群中,积极的 PCI 策略可能是合理的。